BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 7.06.2024

Advisory Committee; Arthritis Advisory Committee; Renewal

The Food and Drug Administration (FDA or the Agency) is announcing the renewal of the Arthritis Advisory Committee by the Commissioner of Food and Drugs (the Commissioner). The Commissioner has determined that it is in the public interest to renew the Arthritis Advisory Committee for an additional 2 years beyond the charter expiration date. The new charter will be in effect until the April 5, 2026, expiration date.

Source: Federal Register — Food and Drug AdministrationOpen original release →